4
Changes in Ownership
Protagenic Therapeutics, Inc.\new Filed Acc 0001144204-10-066734
Exec VP, Corporate Development bought 15,000 shares at an average $1.90 ($28,458)
From the SEC's structured data for this filing
Trades in this filing
MUSCI RAYMOND · Exec VP, Corporate Development
Table I: Non-derivative
14 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2010-12-10 | Purchase : show line 1 in the form | +200 | $1.59 | $318 | 436,021 | D |
| 2010-12-10 | Purchase : show line 2 in the form | +300 | $1.60 | $480 | 436,321 | D |
| 2010-12-10 | Purchase : show line 3 in the form | +600 | $1.63 | $978 | 436,921 | D |
| 2010-12-10 | Purchase : show line 4 in the form | +100 | $1.64 | $164 | 437,021 | D |
| 2010-12-10 | Purchase : show line 5 in the form | +100 | $1.70 | $170 | 437,121 | D |
| 2010-12-10 | Purchase : show line 6 in the form | +3,499 | $1.79 | $6,263 | 440,620 | D |
| 2010-12-10 | Purchase : show line 7 in the form | +5,000 | $1.90 | $9,500 | 445,620 | D |
| 2010-12-13 | Purchase : show line 8 in the form | +266 | $1.97 | $524 | 445,886 | D |
| Open-market purchases · 15,000 sh · avg $1.90 · $28,458 | ||||||
Loading xslF345X03/v205708_ex.xml…